SUTRO BIOPHARMA, INC. (STRO) Operating cash flow 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$177.2MFY2025 · since FY2016: -$13.2M → -$177.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$177.2M | +7.5% |
| FY2024 | -$191.5M | -71.6% |
| FY2023 | -$111.6M | -3245.0% |
| FY2022 | $3.5M | +104.3% |
| FY2021 | -$81.7M | -20.5% |
| FY2020 | -$67.8M | -4.3% |
| FY2019 | -$65.0M | -612.7% |
| FY2018 | $12.7M | +134.2% |
| FY2017 | -$37.1M | -181.9% |
| FY2016 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice